On October 3, 2024, the HELIOS CA22119 COST Action held its inaugural scientific meeting, “Fostering Collaboration and Harmonisation in Haemoglobinopathy Research and Training through Synergistic Networking,” in London. This milestone event took place during the renowned Annual Sickle Cell and Thalassemia (ASCAT) Congress, a three-day gathering from October 2-5 at the ETC Venue. HELIOS members showcased their research to peers and the broader ASCAT audience, sparking lively discussions that allowed members to connect, explore each other’s work, and identify collaborative opportunities.
Throughout ASCAT, HELIOS also ran a dedicated booth, drawing significant interest from participants keen to learn more about the mission and activities of HELIOS. By participating in the HELIOS meeting, members joined the larger ASCAT conference, which welcomed over 800 attendees, offering valuable opportunities to network with hemoglobinopathy experts worldwide. HELIOS also took center stage in a panel discussion and dissemination session, where the Action’s Chair, Dr. Petros Kountouris, and Grant Manager, Dr. Sotiroula Chatzimatthaiou, presented HELIOS’s mission to recruit more experts and enhance efforts in harmonizing hemoglobinopathy management.
We extend our sincere gratitude to the entire ASCAT team for warmly welcoming HELIOS and for organizing such an outstanding event.
Our commitment to fostering connection, collaboration, and innovation remains strong, and we are excited to continue offering impactful networking opportunities for our members!
